United Therapeutics (UTHR) Tops Q1 EPS by $1.69
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $538.30 +0.32%
Revenue Growth %: +1.5%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +1.5%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.03, $1.69 better than the analyst estimate of $3.34. Revenue for the quarter came in at $461.9 million versus the consensus estimate of $420.02 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- NVE Corporation names new CEO and expands board to seven members
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
